0001104659-23-069497.txt : 20230608
0001104659-23-069497.hdr.sgml : 20230608
20230608181351
ACCESSION NUMBER: 0001104659-23-069497
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230606
FILED AS OF DATE: 20230608
DATE AS OF CHANGE: 20230608
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ugwumba Chidozie
CENTRAL INDEX KEY: 0001835544
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36296
FILM NUMBER: 231003284
MAIL ADDRESS:
STREET 1: 158 FILMORE STREET
CITY: DENVER
STATE: CO
ZIP: 80206
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Carisma Therapeutics Inc.
CENTRAL INDEX KEY: 0001485003
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 262025616
STATE OF INCORPORATION: PA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3675 MARKET STREET
STREET 2: SUITE 200
CITY: PHILADELPHIA
STATE: PA
ZIP: 19104
BUSINESS PHONE: 2674916422
MAIL ADDRESS:
STREET 1: 3675 MARKET STREET
STREET 2: SUITE 200
CITY: PHILADELPHIA
STATE: PA
ZIP: 19104
FORMER COMPANY:
FORMER CONFORMED NAME: Sesen Bio, Inc.
DATE OF NAME CHANGE: 20180516
FORMER COMPANY:
FORMER CONFORMED NAME: Eleven Biotherapeutics, Inc.
DATE OF NAME CHANGE: 20100223
4
1
tm2318219-2_4seq.xml
OWNERSHIP DOCUMENT
X0407
4
2023-06-06
0
0001485003
Carisma Therapeutics Inc.
CARM
0001835544
Ugwumba Chidozie
3675 MARKET STREET, SUITE 200
PHILADELPHIA
PA
19104
1
0
0
0
0
Stock Option (Right to Buy)
7.25
2023-06-06
4
A
0
38700
0.00
A
2033-06-06
Common Stock
38700
38700
D
The shares underlying this option vest over three years in equal monthly installments following June 6, 2023, subject to continued service to Carisma Therapeutics Inc. through the applicable vesting date.
/s/ Richard Morris, as Attorney-in-Fact for Chidozie Ugwumba
2023-06-08